Public health management of perinatal hepatitis B virus. Libbus, M. K. & Phillips, L. M Public health nursing (Boston, Mass.), 26(4):353–61, 2009.
abstract   bibtex   
Infants who are born to hepatitis B surface antigen (HbsAg)-positive women are at high risk for contracting perinatal hepatitis B virus (HBV) infection. When maternal status is known, postexposure prophylaxis (PEP) consisting of a birth dose of (HBV) vaccine and Hepatitis B Immune Globulin may be administered within 12 hr of birth to provide 90% protection. Providers' reporting of maternal HBsAg positivity or perinatal HBV should prompt public health nurses to initiate nurse case management (NCM). NCM is the most successful way to ensure that at-risk infants receive PEP and follow-up serology. Unfortunately, reporting laws vary greatly by state and the Centers for Disease Control and Prevention estimate that perinatal HBV is significantly under-reported nationally. This article discusses public health measures for preventing perinatal HBV and presents a case study that used a novel method to assess the extent of under-reporting. We discuss barriers to public health NCM and the importance of a universal HBV vaccine birth dose to protect undetected and unreported cases. Finally, we suggest implications for public health nursing practice.
@article{libbus_public_2009,
	title = {Public health management of perinatal hepatitis {B} virus.},
	volume = {26},
	issn = {1525-1446},
	abstract = {Infants who are born to hepatitis B surface antigen (HbsAg)-positive women are at high risk for contracting perinatal hepatitis B virus (HBV) infection. When maternal status is known, postexposure prophylaxis (PEP) consisting of a birth dose of (HBV) vaccine and Hepatitis B Immune Globulin may be administered within 12 hr of birth to provide 90\% protection. Providers' reporting of maternal HBsAg positivity or perinatal HBV should prompt public health nurses to initiate nurse case management (NCM). NCM is the most successful way to ensure that at-risk infants receive PEP and follow-up serology. Unfortunately, reporting laws vary greatly by state and the Centers for Disease Control and Prevention estimate that perinatal HBV is significantly under-reported nationally. This article discusses public health measures for preventing perinatal HBV and presents a case study that used a novel method to assess the extent of under-reporting. We discuss barriers to public health NCM and the importance of a universal HBV vaccine birth dose to protect undetected and unreported cases. Finally, we suggest implications for public health nursing practice.},
	number = {4},
	journal = {Public health nursing (Boston, Mass.)},
	author = {Libbus, Martha Kay and Phillips, Lynelle M},
	year = {2009},
	keywords = {*Disease Notification/sn [Statistics \& Numerical Data], *Hepatitis B, Chronic/pc [Prevention \& Control], *Infectious Disease Transmission, Vertical/pc [Prevention \& Control], *Patient Discharge/sn [Statistics \& Numerical Data], *Pregnancy Complications, Infectious/pc [Prevention \& Control], *Public Health Practice, Centers for Disease Control and Prevention (U.S.), Disease Notification/lj [Legislation \& Jurisprudence], Disease Notification/mt [Methods], Female, Hepatitis B Vaccines, Hepatitis B, Chronic/ep [Epidemiology], Hepatitis B, Chronic/tm [Transmission], Immunization Programs, Infant, Newborn, Mass Screening, Missouri/ep [Epidemiology], Population Surveillance, Pregnancy, Pregnancy Complications, Infectious/ep [Epidemiology], Prenatal Diagnosis, Public Health Nursing/og [Organization \& Administration], Public Health Practice/lj [Legislation \& Jurisprudence], Public Health Practice/sn [Statistics \& Numerical Data], Risk Factors, United States/ep [Epidemiology], humans},
	pages = {353--61},
}

Downloads: 0